__NUXT_JSONP__("/drugs/Selective_Estrogen_Receptor_Degrader_AZD9496", (function(a,b,c,d){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[],id:b,nciThesaurus:{casRegistry:a,chebiId:a,chemicalFormula:a,definition:"An orally available selective estrogen receptor degrader (SERD), with potential antineoplastic activity. Upon administration, SERD AZD9496 binds to the estrogen receptor (ER) and induces a conformational change that results in the degradation of the receptor. This prevents ER-mediated signaling and inhibits the growth and survival of ER-expressing cancer cells.",fdaUniiCode:"DA9P7LN909",identifier:"C122834",preferredName:c,semanticType:"Organic Chemical",subclassOf:["C2116"],synonyms:["(E)-3-(3,5-Difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)phenyl)acrylic Acid","AZD 9496","AZD-9496","AZD9496","SERD AZD9496",c]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FSelective_Estrogen_Receptor_Degrader_AZD9496",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("","Selective_Estrogen_Receptor_Degrader_AZD9496","Selective Estrogen Receptor Degrader AZD9496","2021-10-30T13:29:59.343Z")));